| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphatic Vessels | 7 | 2024 | 32 | 3.710 |
Why?
|
| Histone Deacetylases | 9 | 2025 | 65 | 3.070 |
Why?
|
| Endothelial Cells | 8 | 2024 | 187 | 2.870 |
Why?
|
| Lymphatic System | 4 | 2024 | 19 | 2.030 |
Why?
|
| Histone Deacetylase 2 | 6 | 2020 | 17 | 1.700 |
Why?
|
| Hemangioendothelioma, Epithelioid | 2 | 2021 | 7 | 1.440 |
Why?
|
| Lymphangiogenesis | 3 | 2024 | 14 | 1.380 |
Why?
|
| Epigenesis, Genetic | 3 | 2025 | 385 | 1.230 |
Why?
|
| Histone Deacetylase 1 | 3 | 2020 | 18 | 1.220 |
Why?
|
| Homeodomain Proteins | 5 | 2015 | 268 | 1.190 |
Why?
|
| Heart Defects, Congenital | 4 | 2023 | 103 | 1.010 |
Why?
|
| Heart | 3 | 2020 | 283 | 0.960 |
Why?
|
| Organogenesis | 3 | 2020 | 39 | 0.950 |
Why?
|
| Lymphatic Abnormalities | 2 | 2024 | 5 | 0.940 |
Why?
|
| Vascular Malformations | 2 | 2024 | 22 | 0.920 |
Why?
|
| Lymphatic Diseases | 1 | 2024 | 13 | 0.890 |
Why?
|
| Myocytes, Cardiac | 5 | 2014 | 99 | 0.880 |
Why?
|
| Metformin | 1 | 2025 | 74 | 0.880 |
Why?
|
| Regeneration | 2 | 2023 | 95 | 0.880 |
Why?
|
| Cell Proliferation | 7 | 2018 | 988 | 0.870 |
Why?
|
| Mice | 27 | 2025 | 10844 | 0.850 |
Why?
|
| Animals | 32 | 2025 | 20663 | 0.840 |
Why?
|
| Cardiomegaly | 5 | 2014 | 34 | 0.830 |
Why?
|
| Mice, Transgenic | 11 | 2021 | 1277 | 0.810 |
Why?
|
| Energy Metabolism | 1 | 2025 | 379 | 0.780 |
Why?
|
| Lymphangiectasis, Intestinal | 1 | 2022 | 3 | 0.780 |
Why?
|
| Lymphedema | 1 | 2022 | 7 | 0.770 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2024 | 429 | 0.770 |
Why?
|
| Channelopathies | 1 | 2022 | 5 | 0.770 |
Why?
|
| Aortic Valve Stenosis | 1 | 2025 | 189 | 0.770 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 95 | 0.760 |
Why?
|
| Transposition of Great Vessels | 1 | 2022 | 2 | 0.750 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 125 | 0.720 |
Why?
|
| Vascular Neoplasms | 1 | 2021 | 17 | 0.710 |
Why?
|
| Transferases | 1 | 2021 | 17 | 0.710 |
Why?
|
| Mitochondria | 2 | 2025 | 371 | 0.700 |
Why?
|
| Blood Vessels | 1 | 2021 | 62 | 0.690 |
Why?
|
| Neural Crest | 3 | 2017 | 27 | 0.660 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 51 | 0.650 |
Why?
|
| Epigenomics | 1 | 2020 | 62 | 0.650 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 56 | 0.650 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 206 | 0.650 |
Why?
|
| Lymph | 1 | 2019 | 10 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2020 | 217 | 0.610 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 188 | 0.600 |
Why?
|
| Liver | 2 | 2020 | 855 | 0.580 |
Why?
|
| Fetal Heart | 2 | 2015 | 5 | 0.580 |
Why?
|
| Humans | 29 | 2025 | 63445 | 0.580 |
Why?
|
| Mice, Knockout | 10 | 2025 | 2109 | 0.580 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2019 | 71 | 0.560 |
Why?
|
| Blood Platelets | 1 | 2019 | 102 | 0.560 |
Why?
|
| Branchial Region | 1 | 2017 | 3 | 0.550 |
Why?
|
| Facial Bones | 1 | 2017 | 10 | 0.550 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 148 | 0.550 |
Why?
|
| Transcriptome | 1 | 2020 | 387 | 0.530 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2019 | 642 | 0.510 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 60 | 0.470 |
Why?
|
| NF-kappa B | 2 | 2007 | 469 | 0.470 |
Why?
|
| Acetylation | 4 | 2025 | 120 | 0.450 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 38 | 0.430 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 1617 | 0.420 |
Why?
|
| Mutation | 2 | 2020 | 2612 | 0.380 |
Why?
|
| Down-Regulation | 2 | 2011 | 319 | 0.380 |
Why?
|
| Gain of Function Mutation | 2 | 2024 | 15 | 0.380 |
Why?
|
| Embryo, Mammalian | 3 | 2018 | 157 | 0.370 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 835 | 0.360 |
Why?
|
| Signal Transduction | 8 | 2024 | 3035 | 0.360 |
Why?
|
| Repressor Proteins | 3 | 2010 | 346 | 0.360 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 3 | 0.340 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2008 | 45 | 0.330 |
Why?
|
| Heart Valves | 2 | 2023 | 26 | 0.330 |
Why?
|
| Myocardium | 2 | 2009 | 279 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 719 | 0.300 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 107 | 0.290 |
Why?
|
| Craniofacial Abnormalities | 2 | 2022 | 22 | 0.290 |
Why?
|
| Membrane Proteins | 2 | 2024 | 895 | 0.290 |
Why?
|
| Umbilical Veins | 1 | 2007 | 12 | 0.270 |
Why?
|
| HEK293 Cells | 4 | 2024 | 622 | 0.270 |
Why?
|
| Gene Expression | 2 | 2015 | 840 | 0.250 |
Why?
|
| Fibroblasts | 2 | 2025 | 394 | 0.240 |
Why?
|
| Transcription Factors | 3 | 2023 | 1513 | 0.230 |
Why?
|
| Inflammation | 2 | 2012 | 1147 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 139 | 0.220 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 16 | 0.220 |
Why?
|
| Cardiovirus Infections | 1 | 2024 | 14 | 0.220 |
Why?
|
| Encephalomyocarditis virus | 1 | 2024 | 15 | 0.220 |
Why?
|
| Endothelium | 1 | 2024 | 21 | 0.220 |
Why?
|
| ADAM Proteins | 1 | 2024 | 32 | 0.210 |
Why?
|
| Veins | 1 | 2024 | 64 | 0.210 |
Why?
|
| Aortic Valve | 1 | 2025 | 190 | 0.210 |
Why?
|
| Lung | 2 | 2024 | 956 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2024 | 81 | 0.200 |
Why?
|
| Myocarditis | 1 | 2024 | 67 | 0.200 |
Why?
|
| Glutamine | 1 | 2023 | 47 | 0.200 |
Why?
|
| Heart Ventricles | 2 | 2023 | 261 | 0.200 |
Why?
|
| Heart Failure | 1 | 2011 | 913 | 0.200 |
Why?
|
| Homeostasis | 1 | 2025 | 368 | 0.200 |
Why?
|
| Basement Membrane | 1 | 2022 | 25 | 0.190 |
Why?
|
| Pyridones | 1 | 2022 | 40 | 0.190 |
Why?
|
| Interferon Type I | 1 | 2024 | 187 | 0.190 |
Why?
|
| Cations | 1 | 2022 | 64 | 0.190 |
Why?
|
| Histones | 1 | 2025 | 481 | 0.190 |
Why?
|
| Adipose Tissue, Brown | 1 | 2023 | 118 | 0.190 |
Why?
|
| Pyrimidines | 1 | 2022 | 137 | 0.180 |
Why?
|
| Models, Biological | 2 | 2020 | 1180 | 0.180 |
Why?
|
| Arteries | 1 | 2022 | 81 | 0.180 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 101 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 39 | 0.180 |
Why?
|
| Cadherins | 1 | 2021 | 80 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2187 | 0.170 |
Why?
|
| Histone Code | 1 | 2020 | 26 | 0.170 |
Why?
|
| Adherens Junctions | 1 | 2020 | 9 | 0.170 |
Why?
|
| Embryo Loss | 1 | 2020 | 12 | 0.170 |
Why?
|
| Risk Factors | 2 | 2021 | 5354 | 0.160 |
Why?
|
| Echocardiography | 1 | 2023 | 501 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2021 | 347 | 0.160 |
Why?
|
| Cell Communication | 1 | 2020 | 130 | 0.160 |
Why?
|
| Smoke | 1 | 2019 | 24 | 0.150 |
Why?
|
| Aerosols | 1 | 2019 | 47 | 0.150 |
Why?
|
| Hemostasis | 1 | 2019 | 18 | 0.150 |
Why?
|
| Genetic Variation | 1 | 2021 | 383 | 0.150 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2018 | 10 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 234 | 0.150 |
Why?
|
| Male | 6 | 2025 | 29891 | 0.150 |
Why?
|
| Chromatin | 1 | 2023 | 608 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 525 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2024 | 795 | 0.140 |
Why?
|
| GATA2 Transcription Factor | 1 | 2017 | 8 | 0.140 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 44 | 0.140 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2017 | 9 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2018 | 127 | 0.140 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 81 | 0.140 |
Why?
|
| Phenotype | 1 | 2021 | 1207 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 175 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2018 | 311 | 0.130 |
Why?
|
| Cell Lineage | 2 | 2015 | 270 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2011 | 1537 | 0.130 |
Why?
|
| Female | 5 | 2025 | 32880 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 878 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2015 | 1353 | 0.120 |
Why?
|
| Body Patterning | 1 | 2015 | 82 | 0.120 |
Why?
|
| Pulmonary Alveoli | 1 | 2015 | 41 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 905 | 0.110 |
Why?
|
| Base Sequence | 1 | 2017 | 1331 | 0.110 |
Why?
|
| Macrophages | 1 | 2020 | 1039 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 43 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2013 | 216 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 198 | 0.100 |
Why?
|
| MSX1 Transcription Factor | 1 | 2013 | 1 | 0.100 |
Why?
|
| Face | 1 | 2013 | 36 | 0.100 |
Why?
|
| Skull | 1 | 2013 | 50 | 0.100 |
Why?
|
| Hyperplasia | 2 | 2014 | 88 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2012 | 612 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2013 | 113 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2015 | 390 | 0.100 |
Why?
|
| Bronchoconstriction | 1 | 2012 | 9 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2012 | 321 | 0.090 |
Why?
|
| Isoproterenol | 2 | 2009 | 36 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 27 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 36 | 0.090 |
Why?
|
| Cellular Reprogramming | 1 | 2011 | 37 | 0.090 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 134 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 615 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2011 | 233 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2008 | 32 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 109 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 74 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 149 | 0.080 |
Why?
|
| Rats | 2 | 2011 | 1980 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 127 | 0.080 |
Why?
|
| Luciferases | 1 | 2010 | 109 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5462 | 0.080 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 17 | 0.080 |
Why?
|
| Hyperoxia | 1 | 2010 | 17 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 248 | 0.080 |
Why?
|
| Respiratory Mucosa | 1 | 2010 | 54 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 3396 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2009 | 47 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 128 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 263 | 0.080 |
Why?
|
| Aged | 1 | 2025 | 14447 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.080 |
Why?
|
| Myoblasts, Cardiac | 1 | 2008 | 2 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2008 | 16 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 53 | 0.070 |
Why?
|
| Pregnancy | 1 | 2015 | 2334 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2008 | 239 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 15 | 0.070 |
Why?
|
| E-Selectin | 1 | 2007 | 18 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 50 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 54 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2008 | 309 | 0.070 |
Why?
|
| Asthma | 1 | 2012 | 459 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 770 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 190 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2157 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2007 | 140 | 0.060 |
Why?
|
| Fetus | 1 | 2007 | 99 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 235 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 374 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2007 | 381 | 0.060 |
Why?
|
| Transfection | 1 | 2007 | 694 | 0.060 |
Why?
|
| Biomarkers | 1 | 2010 | 1408 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 676 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 687 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2018 | 302 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1991 | 0.050 |
Why?
|
| Adult | 1 | 2020 | 16824 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2024 | 201 | 0.050 |
Why?
|
| Middle Aged | 1 | 2020 | 17613 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 140 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2023 | 121 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 896 | 0.050 |
Why?
|
| Glucose | 1 | 2023 | 467 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2008 | 769 | 0.040 |
Why?
|
| Cell Size | 2 | 2009 | 41 | 0.040 |
Why?
|
| Neural Tube | 1 | 2018 | 12 | 0.040 |
Why?
|
| Homozygote | 1 | 2018 | 124 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 41 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2018 | 116 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 197 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 741 | 0.040 |
Why?
|
| Necrosis | 1 | 2018 | 143 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2018 | 136 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 284 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2015 | 7 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 110 | 0.030 |
Why?
|
| Clone Cells | 1 | 2015 | 114 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2015 | 41 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2014 | 15 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2014 | 48 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 204 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 257 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 172 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2015 | 113 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 182 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 367 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 250 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 517 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2013 | 18 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 207 | 0.020 |
Why?
|
| Carbachol | 1 | 2012 | 17 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 93 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 2011 | 6 | 0.020 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2011 | 4 | 0.020 |
Why?
|
| PAX3 Transcription Factor | 1 | 2011 | 12 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 16 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2011 | 12 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 7 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 182 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2012 | 141 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 10 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 2011 | 27 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2011 | 30 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 84 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 104 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2012 | 205 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 67 | 0.020 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2009 | 8 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 2009 | 17 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 99 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 536 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2010 | 103 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 301 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 453 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 293 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2011 | 191 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 575 | 0.020 |
Why?
|